381 related articles for article (PubMed ID: 37102247)
1. Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies.
Bychowski J; Sobiczewski W
Cancer Med; 2023 Jul; 12(13):14545-14555. PubMed ID: 37102247
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
3. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
4. Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.
Biasillo G; Cipolla CM; Cardinale D
Curr Oncol Rep; 2017 Aug; 19(8):55. PubMed ID: 28707189
[TBL] [Abstract][Full Text] [Related]
5. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
6. New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies.
Lanza O; Ferrera A; Reale S; Solfanelli G; Petrungaro M; Tini Melato G; Volpe M; Battistoni A
Med Sci (Basel); 2022 May; 10(2):. PubMed ID: 35736347
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope.
Mittal R; Krishnan M P S; Saxena R; Sampath A; Goyal B
Cancer Treat Res Commun; 2023; 36():100750. PubMed ID: 37531735
[TBL] [Abstract][Full Text] [Related]
8. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
[TBL] [Abstract][Full Text] [Related]
9. Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
Chow EJ; Leger KJ; Bhatt NS; Mulrooney DA; Ross CJ; Aggarwal S; Bansal N; Ehrhardt MJ; Armenian SH; Scott JM; Hong B
Cardiovasc Res; 2019 Apr; 115(5):922-934. PubMed ID: 30768157
[TBL] [Abstract][Full Text] [Related]
10. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
Tufano A; Coppola A; Galderisi M
Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
[TBL] [Abstract][Full Text] [Related]
12. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
13. Cardio-oncology: cardiovascular complications of cancer therapy.
Henning RJ; Harbison RD
Future Cardiol; 2017 Jul; 13(4):379-396. PubMed ID: 28660778
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Dysfunction and Chemotherapeutic Agents.
Clasen SC; Wald JW
Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
[TBL] [Abstract][Full Text] [Related]
15. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
17. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
Andres MS; Pan J; Lyon AR
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
[TBL] [Abstract][Full Text] [Related]
18. Heart failure and chemotherapeutic agents.
Piper S; McDonagh T
Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced cardiomyopathy.
Higgins AY; O'Halloran TD; Chang JD
Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
[TBL] [Abstract][Full Text] [Related]
20. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
